Skip to main content
SpringerLink
Log in

MCAM expression is associated with poor prognosis in non-small cell lung cancer

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

MCAM has been recently identified as a biomarker for epithelial–mesenchymal transition (EMT) and is potentially involved in metastasis of cancer. The current study aimed at investigating the expression of MCAM in non-small-cell lung cancer (NSCLC) and its clinico-pathological significance.

Methods

A follow-up analysis was performed on 118 patients with NSCLC resected by lobectomy or pneumectomy with systematic lymph node dissection. All patients were followed for 6–60 months. Immunostaining of tissue sections from primary tumors and their lymph node metastasis was performed and evaluated using monoclonal antibody against MCAM, E-cadherin, and vimentin. Correlations were investigated between MCAM immunostaining in primary tumors and E-cadherin, vimentin immunostaining, lymph node metastasis, and survival.

Results

MCAM protein expression was found in 46.61 % of squamous cell carcinomas and 37.47 % of adenocarcinomas; MCAM expression positively correlated with vimentin, but inversely with E-cadherin (both P values <0.05). There were significant correlations between the MCAM immunostaining score in primary tumors and in their lymph node metastasis (P = 0.03). According to the Kaplan–Meier survival estimate, the level of MCAM expression in primary tumors was a statistically significant prognostic factor (P < 0.05).

Conclusions

MCAM expression in surgically treated NSCLC is clearly associated with lymph node metastasis and poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013;63(1):11–30.

    Article  PubMed  Google Scholar 

  2. Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR et al. NCCN Clinical Practice Guidelines in Oncology Non-small cell lung cancer Version 3. 2011. National comprehensive cancer network. http://www.nccn.com (2011) Accessed 7 June 2011.

  3. Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I non-small cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California cancer registry from 1989 to 2003. Cancer. 2007;110(7):1532–41.

    Article  PubMed  Google Scholar 

  4. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350(4):379–92.

    Article  CAS  PubMed  Google Scholar 

  5. Thiery JP. Epithelial–mesenchymal transition in tumor progression. Nat Rev Cancer. 2002;2(6):442–54.

    Article  CAS  PubMed  Google Scholar 

  6. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;17(5):548–58.

    Article  CAS  PubMed  Google Scholar 

  7. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial–mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172(7):973–81.

    Article  CAS  PubMed  Google Scholar 

  8. Myong NH. Reduced expression of E-cadherin in human non-small cell lung carcinoma. Cancer Res Treat. 2004;36(1):56–61.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Sers C, Kirsch K, Rothbacher U, Riethmuller G, Johnson JP. Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains. Proc Natl Acad Sci USA. 1993;90(18):8514–8.

    Article  CAS  PubMed  Google Scholar 

  10. Wang Z, Yan X. CD146, a multi-functional molecule beyond adhesion. Cancer Lett. 2013;330(2):150–62.

    Article  CAS  PubMed  Google Scholar 

  11. Bardin N, Anfosso F, Masse JM, Cramer E, Sabatier F, Le Bivic A, et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell–cell cohesion. Blood. 2001;98(13):3677–84.

    Article  CAS  PubMed  Google Scholar 

  12. Shih IM, Speicher D, Hsu MY, Levine E, Herlyn M. Melanoma cell–cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Cancer Res. 1997;57(17):3835–40.

    CAS  PubMed  Google Scholar 

  13. Wu GJ, Peng Q, Fu P, Wang SW, Chiang CF, Dillehay DL, et al. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene. 2004;327(2):201–13.

    Article  CAS  PubMed  Google Scholar 

  14. Aldovini D, Demichelis F, Doglioni C, Di Vizio D, Galligioni E, Brugnara S, et al. MCAM expression as marker of poor prognosis in epithelial ovarian cancer. Int J Cancer. 2006;119(8):1920–6.

    Article  CAS  PubMed  Google Scholar 

  15. Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, et al. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res. 2009;11(1):R1.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, et al. Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Cancer Res. 2009;69(4):1570–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Wang W, Yang ZL, Liu JQ, Jiang S, Miao XY. Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma. Tumor Biol. 2012;33(1):173–82.

    Article  Google Scholar 

  18. Liu WF, Ji SR, Sun JJ, Zhang Y, Liu ZY, Liang AB, et al. CD146 expression correlates with epithelial–mesenchymal transition markers and a poor prognosis in gastric cancer. Int J Mol Sci. 2012;13(5):6399–406.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Schlagbauer-Wadl H, Jansen B, Muller M, Polterauer P, Wolff K, Eichler HG, et al. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice. Int J Cancer. 1999;81(6):951–5.

    Article  CAS  PubMed  Google Scholar 

  20. Zeng GF, Cai SX, Wu GJ. Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells. BMC Cancer. 2011;11:113.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Zeng Q, Li W, Lu D, Wu Z, Duan H, Luo Y, et al. CD146, an epithelial–mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci USA. 2012;109(4):1127–32.

    Article  CAS  PubMed  Google Scholar 

  22. Imbert AM, Garulli C, Choquet E, Koubi M, Aurrand-Lions M, Chabannon C. CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in epithelial–mesenchymal transition. PLoS ONE. 2012;7(8):e43752.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Kristiansen G, Yu Y, Schluns K, Sers C, Dietel M, Petesen I. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Anal Cell Pathol. 2003;25:77–81.

    CAS  PubMed  Google Scholar 

  24. Oka S, Uramoto H, Chikaishi Y, Tanaka F. The expression of CD146 predicts a poor overall survival in patients with adenocarcinoma of the lung. Anticancer Res. 2012;32(3):861–4.

    PubMed  Google Scholar 

  25. Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC. World health organization classifications of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. 2nd ed. Lyon: IARC Press; 2004.

    Google Scholar 

  26. Tischler V, Pfeifer M, Hausladen S, Schrimer U, Bonde AK, Kristiansen G, et al. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol Cancer. 2011;10:127.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Wu Z, Wu Z, Li J, Yang X, Wang Y, Yu Y, et al. MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells. Tumour Biol. 2012;33(5):1619–28.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68(18):3033–46.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Zigler M, Villares GJ, Dobroff AS, Wang H, Huang L, Braeuer RR, et al. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Res. 2011;71(10):3494–504.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Zeng G, Cai S, Liu Y, Wu GJ. METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells. Gene. 2012;492(1):229–38.

    Article  CAS  PubMed  Google Scholar 

  31. Chen W, Zhang HL, Jiang YG, Li JH, Liu BL, Sun MY. Inhibition of CD146 gene expression via RNA interference reduces in vitro perineural invasion on ACC-M cell. J Oral Pathol Med. 2009;38(2):198–205.

    Article  PubMed  Google Scholar 

  32. Leslie MC, Zhao YJ, Lachman LB, Hwu P, Wu GJ, Bar-Eli M. Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis. Gene Ther. 2007;14(4):316–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The present study was supported by funds from Ministry of Health of Henan province (To X.-J.Z).

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Respiratory and Critical Care Medicine, People’s Hospital of Zhengzhou University, Weiwu Road 7, Zhengzhou, Henan, China

    X. Zhang, Z. Wang, X. Li, X. Ma & L. Ma

  2. Department of Infectious Disease, People’s Hospital of Zhengzhou University, Weiwu Road 7, Zhengzhou, Henan, China

    Y. Kang

Authors
  1. X. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. X. Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Ma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, X., Wang, Z., Kang, Y. et al. MCAM expression is associated with poor prognosis in non-small cell lung cancer. Clin Transl Oncol 16, 178–183 (2014). https://doi.org/10.1007/s12094-013-1057-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-013-1057-6

Keywords

Search

Navigation